
  
    
      
        Introduction_NNP
        
          Objective_NNP of_IN the_DT study_NN
          The_DT purpose_NN of_IN this_DT study_NN was_VBD to_TO test_VB whether_IN a_DT
          low-cost_JJ outreach_NN education_NN programme_NN ,_, managed_VBN by_IN a_DT
          district_NN health_NN management_NN team_NN (_( DHMT_NNP )_) in_IN a_DT rural_JJ
          district_NN of_IN Kenya_NNP ,_, could_MD increase_VB private_JJ drug_NN outlets_NNS '_POS
          knowledge_NN of_IN and_CC compliance_NN with_IN national_JJ malaria_NN
          treatment_NN guidelines_NNS ._. The_DT cornerstone_NN of_IN the_DT programme_NN
          was_VBD to_TO train_VB and_CC equip_VB drug_NN wholesalers_NNS -_: both_DT mobile_JJ
          drug_NN vendors_NNS and_CC wholesale_JJ counter_NN attendants_NNS -_: to_TO serve_VB
          as_IN unpaid_JJ outreach_NN educators_NNS of_IN the_DT new_JJ malaria_NN
          guidelines_NNS ._. Since_IN the_DT wholesalers_NNS were_VBD to_TO educate_VB the_DT
          drug_NN retailers_NNS during_IN their_PRP$ normal_JJ business_NN interactions_NNS
          with_IN them_PRP ,_, the_DT programme_NN was_VBD called_VBN "_'' vendor-to-vendor_JJ ._. "_''
          Retailers_NNS consisted_VBD of_IN shops_NNS ,_, kiosks_NNS ,_, pharmacies_NNS and_CC
          private_JJ clinics_NNS ,_, many_JJ of_IN them_PRP unlicensed_JJ ._.
        
        
          Study_NNP setting_VBG
          In_IN Kenya_NNP ,_, approximately_RB 26_CD ,_, 000_CD children_NNS die_VBP each_DT year_NN
          from_IN malaria_NN ,_, or_CC about_IN 72_CD per_IN day_NN [_NN 9_CD ]_NN ._. In_IN August_NNP 1998_CD
          the_DT Government_NNP of_IN Kenya_NNP changed_VBD its_PRP$ first-line_JJ
          anti-malarial_JJ treatment_NN from_IN chloroquine_NN to_TO
          sulfadoxine-pyrimethamine_JJ (_( SP_NNP )_) [_NN 10_CD ]_NN ._. Amodiaquine_NNP was_VBD
          to_TO be_VB the_DT second-line_JJ drug_NN ._. A_DT gazette_NN notice_NN in_IN October_NNP
          1999_CD permitted_VBN SP_NNP to_TO be_VB sold_VBN over_IN the_DT counter_NN and_CC
          required_VBN that_DT chloroquine_NN be_VB sold_VBN only_RB by_IN prescription_NN ._.
          (_( Amodiaquine_NNP was_VBD not_RB mentioned_VBN ,_, so_IN it_PRP continued_VBD to_TO be_VB
          sold_VBN over_IN the_DT counter_NN ._. )_) In_IN 1999_CD the_DT Government_NNP of_IN Kenya_NNP
          also_RB conducted_VBD tests_NNS of_IN 33_CD SP_NNP brands_NNS and_CC approved_VBD five_CD ._.
          However_RB ,_, because_IN of_IN lack_NN of_IN enforcement_NN ,_, the_DT 28_CD
          unapproved_JJ SP_NNP drugs_NNS still_RB remained_VBD in_IN the_DT market_NN ,_, as_RB well_RB
          as_IN chloroquine_NN and_CC amodiaquine_NN ._. Furthermore_RB ,_, the_DT gazette_NN
          notice_NN was_VBD not_RB well-publicized_JJ ,_, so_RB many_JJ shops_NNS and_CC kiosks_NNS
          still_RB believed_VBN that_IN they_PRP were_VBD prohibited_VBN from_IN selling_VBG
          SP_NNP ._.
          Bungoma_NNP district_NN ,_, located_VBN in_IN Western_NNP Province_NNP ,_, Kenya_NNP ,_,
          is_VBZ a_DT malaria_NN endemic_JJ area_NN with_IN a_DT population_NN of_IN about_IN
          900_CD ,_, 000_CD [_NN 11_CD ]_NN ._. Home_NNP treatment_NN of_IN malaria_NN ,_, using_VBG drugs_NNS
          purchased_VBN from_IN private_JJ outlets_NNS ,_, is_VBZ common_JJ ._. A_DT 1996_CD study_NN
          found_VBD that_IN 47_CD %_NN of_IN children_NNS received_VBD home_NN treatment_NN with_IN
          an_DT anti-malarial_JJ drug_NN ,_, purchased_VBD mainly_RB from_IN pharmacies_NNS
          (_( 54_CD %_NN )_) or_CC small_JJ shops_NNS (_( 29_CD %_NN )_) [_NN 5_CD ]_NN ._. A_DT 1998_CD survey_NN
          conducted_VBN by_IN the_DT Bungoma_NNP DHMT_NNP estimated_VBD the_DT district_NN had_VBD
          about_IN 1500_CD private_JJ drug_NN outlets_NNS (_( as_IN compared_VBN to_TO 38_CD health_NN
          facilities_NNS )_) ._. The_DT survey_NN revealed_VBD that_IN 87_CD %_NN of_IN the_DT
          shopkeepers_NNS had_VBD never_RB received_VBN training_VBG on_IN drug_NN use_NN ,_, but_CC
          60_CD %_NN gave_VBD their_PRP$ customers_NNS some_DT instruction_NN on_IN dosages_NNS ._.
          Nearly_RB 27_CD %_NN did_VBD not_RB know_VB the_DT difference_NN between_IN
          anti-malarials_JJ and_CC anti-pyretics_JJ [_NN 11_CD ]_NN ._.
        
        
          Description_NNP of_IN the_DT programme_NN
          The_DT main_JJ components_NNS of_IN the_DT vendor-to-vendor_JJ programme_NN
          were_VBD :_: design_NN and_CC production_NN of_IN a_DT shopkeeper_NN job_NN aid_NN and_CC a_DT
          client_NN awareness_NN aid_NN ,_, orientation_NN of_IN wholesale_JJ owners_NNS ,_,
          training_NN and_CC equipping_VBG of_IN mobile_JJ vendors_NNS and_CC wholesale_JJ
          counter_NN attendants_NNS ,_, and_CC monitoring_VBG ._.
          With_IN the_DT assistance_NN of_IN the_DT USAID-funded_NNP Quality_NNP
          Assurance_NNP Project_NNP and_CC the_DT African_NNP Medical_NNP Research_NNP and_CC
          Education_NNP Foundation_NNP ,_, members_NNS of_IN the_DT Bungoma_NNP DHMT_NNP first_RB
          conducted_VBD focus_VB groups_NNS and_CC individual_JJ interviews_NNS with_IN
          private_JJ drug_NN outlets_NNS ,_, wholesalers_NNS ,_, and_CC consumers_NNS ._. They_PRP
          learned_VBD the_DT common_JJ misperceptions_NNS the_DT public_RB had_VBD about_IN SP_NNP
          (_( e_SYM ._. g_SYM ._. ,_, that_IN it_PRP is_VBZ "_'' too_RB strong_JJ "_'' for_IN children_NNS below_IN one_CD
          year_NN of_IN age_NN )_) ,_, and_CC the_DT main_JJ difficulties_NNS faced_VBN by_IN drug_NN
          sellers_NNS (_( e_SYM ._. g_SYM ._. ,_, when_WRB consumers_NNS demand_VBP anti-malarial_JJ drugs_NNS
          of_IN doubtful_JJ efficacy_NN )_) ._. The_DT team_NN then_RB worked_VBD with_IN a_DT Kenyan_NNP
          graphic_JJ artist_NN to_TO develop_VB two_CD posters_NNS in_IN Kiswahili_NNP to_TO
          communicate_VB Kenya_NNP 's_POS new_JJ malaria_NN guidelines_NNS to_TO retailers_NNS
          and_CC to_TO motivate_VB the_DT public_NN to_TO purchase_VB the_DT approved_VBN SP_NNP
          drugs_NNS ._.
          •_NN The_DT 
          shopkeeper_NN job_NN aid_NN was_VBD for_IN a_DT retailer_NN
          to_TO consult_VB when_WRB selling_VBG anti-malarial_JJ drugs_NNS ._. It_PRP was_VBD to_TO be_VB
          hung_VBN where_WRB the_DT retailer_NN could_MD easily_RB use_VB it_PRP when_WRB serving_VBG
          clients_NNS ._. The_DT job_NN aid_NN listed_VBD the_DT clinical_JJ symptoms_NNS of_IN
          malaria_NN ,_, a_DT dosage_NN chart_NN of_IN the_DT approved_VBN brands_NNS of_IN SP_NNP and_CC
          anti-pyretics_JJ ,_, treatment_NN advice_NN ,_, and_CC common_JJ situations_NNS
          faced_VBN by_IN private_JJ outlets_NNS with_IN suggestions_NNS on_IN how_WRB to_TO deal_VB
          with_IN them_PRP ._.
          •_NN The_DT 
          client_NN awareness_NN poster_NN was_VBD to_TO be_VB
          hung_VBN near_IN the_DT entrance_NN of_IN the_DT outlet_NN to_TO generate_VB consumer_NN
          demand_NN for_IN the_DT five_CD approved_VBD brands_NNS of_IN SP_NNP and_CC to_TO
          communicate_VB that_IN SP_NNP was_VBD now_RB available_JJ over_IN the_DT counter_NN ._.
          It_PRP urged_VBD customers_NNS to_TO treat_VB malaria_NN properly_RB by_IN using_VBG one_CD
          of_IN these_DT recommended_VBN drugs_NNS which_WDT were_VBD depicted_VBN in_IN their_PRP$
          actual_JJ packaging_NN ._.
          The_DT DHMT_NNP next_RB conducted_VBD two_CD three-hour_JJ orientation_NN
          sessions_NNS for_IN owners_NNS of_IN wholesale_JJ shops_NNS and_CC pharmacies_NNS to_TO
          gain_VB their_PRP$ cooperation_NN ._. Following_VBG these_DT sessions_NNS ,_,
          virtually_RB all_DT agreed_VBD to_TO send_VB their_PRP$ counter_NN attendants_NNS to_TO
          the_DT training_NN and_CC let_VB them_PRP distribute_VB the_DT job_NN aids_NNS and_CC
          posters_NNS during_IN their_PRP$ work_NN ._.
          In_IN April-_NNP May_NNP 2000_CD ,_, the_DT DHMT_NNP conducted_VBD five_CD one-day_JJ
          training_NN sessions_NNS for_IN mobile_JJ vendors_NNS and_CC wholesale_JJ
          counter_NN attendants_NNS ._. Mobile_NNP vendors_NNS are_VBP entrepreneurs_NNS who_WP
          purchase_VBP drugs_NNS from_IN wholesale_JJ general_JJ shops_NNS (_( not_RB
          wholesale_JJ pharmacies_NNS )_) and_CC re-sell_JJ them_PRP by_IN motorcycle_NN or_CC
          bicycle_NN to_TO small_JJ retailers_NNS ;_: wholesale_JJ counter_NN attendants_NNS
          are_VBP stationary_JJ employees_NNS of_IN wholesale_JJ pharmacies_NNS or_CC
          general_JJ shops_NNS who_WP are_VBP paid_VBN a_DT daily_JJ wage_NN ._. Of_IN approximately_RB
          105_CD wholesalers_NNS identified_VBN ,_, about_IN 70_CD %_NN were_VBD trained_VBN :_: 22_CD
          wholesale_JJ pharmacy_NN attendants_NNS ,_, 11_CD wholesale_JJ shop_NN
          attendants_NNS ,_, and_CC 40_CD mobile_JJ drug_NN vendors_NNS ._. Extensive_NNP role_NN
          plays_NNS were_VBD performed_VBN on_IN how_WRB to_TO communicate_VB the_DT posters_NNS
          and_CC advise_VB outlets_NNS on_IN where_WRB to_TO hang_VB them_PRP ._. Additionally_RB ,_,
          each_DT trainee_NN received_VBD a_DT receipt_NN book_NN to_TO record_VB recipients_NNS
          of_IN posters_NNS and_CC to_TO obtain_VB their_PRP$ agreement_NN to_TO comply_VB with_IN
          the_DT new_JJ guidelines_NNS ._. Wholesalers_NNS were_VBD to_TO discuss_VB and_CC
          distribute_VB the_DT job_NN aids_NNS at_IN the_DT point_NN of_IN sale_NN :_: for_IN mobile_JJ
          vendors_NNS ,_, at_IN the_DT retail_JJ outlet_NN ;_: for_IN wholesale_JJ attendants_NNS ,_,
          at_IN the_DT wholesale_JJ outlet_NN ._. No_DT retail_JJ outlets_NNS were_VBD directly_RB
          trained_VBN by_IN the_DT DHMT_NNP ._. At_IN the_DT end_NN of_IN the_DT training_NN ,_, all_DT
          wholesalers_NNS received_VBD caps_NNS and_CC shirts_NNS with_IN the_DT malaria_NN
          dosage_NN chart_NN on_IN the_DT front_NN ._.
          About_IN three_CD months_NNS after_IN training_VBG ,_, the_DT DHMT_NNP monitored_VBD
          the_DT mobile_JJ vendors_NNS and_CC wholesale_JJ counter_NN attendants_NNS ._.
          During_IN the_DT visits_NNS ,_, the_DT team_NN checked_VBD malaria_NN knowledge_NN
          with_IN a_DT 10_CD -_: question_NN quiz_NN and_CC collected_VBN receipts_NNS ._. Although_IN
          the_DT DHMT_NNP was_VBD not_RB able_JJ to_TO observe_VB how_WRB the_DT wholesalers_NNS
          communicated_VBD the_DT guidelines_NNS to_TO the_DT retail_JJ outlets_NNS ,_, they_PRP
          were_VBD able_JJ to_TO confirm_VB that_IN the_DT wholesalers_NNS had_VBD the_DT
          requisite_JJ knowledge_NN and_CC understood_VBD every_DT element_NN of_IN the_DT
          shopkeeper_NN job_NN aid_NN ._.
          The_DT total_JJ cost_NN of_IN the_DT programme_NN that_WDT would_MD be_VB borne_VBN by_IN
          a_DT district_NN was_VBD $_$ 8300_CD ._. The_DT cost_NN breakdown_NN was_VBD as_IN follows_VBZ :_:
          formative_JJ research_NN to_TO learn_VB about_IN malaria_NN treatment_NN
          issues_NNS (_( $_$ 2000_CD )_) ;_: design_NN and_CC production_NN of_IN 1500_CD shopkeeper_NN
          job_NN aids_NNS and_CC 1500_CD client_NN posters_NNS (_( $_$ 3000_CD )_) ;_: training_NN of_IN
          mobile_JJ vendors_NNS and_CC wholesale_JJ counter_NN attendants_NNS ,_,
          including_VBG t-shirts_JJ ,_, caps_NNS and_CC receipt_NN books_NNS (_( $_$ 2800_CD )_) ;_: and_CC
          monitoring_NN of_IN mobile_JJ vendors_NNS and_CC wholesale_JJ counter_NN
          attendants_NNS by_IN the_DT DHMT_NNP (_( $_$ 500_CD )_) ._. These_DT costs_NNS do_VBP not_RB include_VB
          the_DT time_NN spent_VBD on_IN this_DT activity_NN by_IN district_NN health_NN
          personnel_NNS or_CC by_IN outside_IN technical_JJ advisors_NNS ,_, but_CC it_PRP does_VBZ
          include_VB daily_JJ allowances_NNS to_TO district_NN personnel_NNS for_IN the_DT
          days_NNS they_PRP spent_VBD in_IN training_NN or_CC monitoring_VBG ._.
        
      
      
        Methods_NNP
        
          Research_NN design_NN
          Six_CD months_NNS after_IN training_VBG the_DT mobile_JJ vendors_NNS and_CC
          wholesale_JJ attendants_NNS ,_, the_DT study_NN team_NN employed_VBN eight_CD
          mystery_NN shoppers_NNS (_( unemployed_JJ people_NNS posing_VBG as_IN clients_NNS )_)
          and_CC four_CD supervisors_NNS (_( members_NNS of_IN the_DT DHMT_NNP )_) to_TO assess_VB the_DT
          implementation_NN and_CC impact_NN of_IN the_DT programme_NN ._. The_DT mystery_NN
          shopper_NN evaluation_NN approach_NN was_VBD chosen_VBN because_IN it_PRP has_VBZ
          been_VBN used_VBN effectively_RB elsewhere_RB to_TO assess_VB the_DT quality_NN of_IN
          drug_NN retailers_NNS (_( primarily_RB dispensing_VBG practices_NNS for_IN
          diarrhoea_NN and_CC respiratory_JJ infections_NNS )_) without_IN observation_NN
          bias_NN [_NN 12_CD ]_NN ._. The_DT study_NN team_NN received_VBD clearance_NN for_IN using_VBG
          this_DT approach_NN from_IN the_DT Steering_NNP Committee_NNP overseeing_VBG the_DT
          Bungoma_NNP District_NNP Malaria_NNP Initiative_NNP during_IN their_PRP$ 1999_CD
          annual_JJ meeting_NN ,_, which_WDT included_VBD representatives_NNS from_IN the_DT
          National_NNP Malaria_NNP Control_NNP Programme_NNP and_CC the_DT Ministry_NNP of_IN
          Health_NNP ._. Care_NNP was_VBD taken_VBN to_TO follow_VB ethical_JJ guidelines_NNS ,_, such_JJ
          as_IN preserving_VBG confidentiality_NN of_IN individual_JJ outlets_NNS ._.
          Data_NNP were_VBD collected_VBN for_IN eight_CD days_NNS ._. Two_CD mystery_NN
          shoppers_NNS (_( one_CD man_NN and_CC one_CD woman_NN )_) and_CC one_CD supervisor_NN
          visited_VBD each_DT drug_NN outlet_NN included_VBN in_IN the_DT sample_NN ._. The_DT
          females_NNS were_VBD to_TO have_VB a_DT nine-month_JJ old_JJ child_NN at_IN home_NN whom_WP
          they_PRP believed_VBD had_VBD malaria_NN ._. They_PRP asked_VBD the_DT outlet_NN
          attendant_NN for_IN advice_NN on_IN what_WP drug_NN to_TO purchase_VB ._. The_DT males_NNS
          were_VBD to_TO have_VB a_DT two-year_JJ old_JJ child_NN sick_JJ at_IN home_NN ._. They_PRP
          specifically_RB asked_VBD for_IN Malaraquin_NNP (_( a_DT popular_JJ brand_NN of_IN
          chloroquine_NN )_) ._. Both_DT types_NNS of_IN mystery_NN shoppers_NNS were_VBD only_RB to_TO
          provide_VB information_NN (_( e_SYM ._. g_SYM ._. ,_, age_NN of_IN the_DT child_NN ,_, duration_NN of_IN
          the_DT illness_NN ,_, etc_FW ._. )_) if_IN asked_VBD ._. Immediately_RB after_IN leaving_VBG
          the_DT outlet_NN ,_, the_DT shopper_NN discreetly_RB completed_VBD a_DT form_NN to_TO
          record_VB the_DT interaction_NN ._. Some_DT time_NN after_IN both_DT mystery_NN
          shoppers_NNS visited_VBD an_DT outlet_NN ,_, a_DT supervisor_NN entered_VBD to_TO check_VB
          stocks_NNS ,_, look_VB for_IN job_NN aids_NNS ,_, and_CC ask_VB questions_NNS to_TO assess_VB
          malaria_NN knowledge_NN ._.
        
        
          Sample_NNP design_NN
          Determining_VBG an_DT appropriate_JJ sample_NN design_NN posed_VBD some_DT
          challenges_NNS ._. First_LS ,_, since_IN the_DT DHMT_NNP had_VBD no_DT control_NN over_IN
          which_WDT retail_JJ outlets_NNS were_VBD reached_VBN by_IN the_DT wholesalers_NNS ,_, it_PRP
          was_VBD not_RB possible_JJ to_TO randomize_NN outlets_NNS into_IN intervention_NN
          and_CC control_NN groups_NNS or_CC localities_NNS ._. Second_JJ ,_, because_IN the_DT
          DHMT_NNP had_VBD conducted_VBN its_PRP$ own_JJ survey_NN of_IN private_JJ drug_NN outlets_NNS
          in_IN Bungoma_NNP district_NN only_RB two_CD years_NNS before_IN implementing_VBG
          the_DT vendor-to-vendor_JJ programme_NN ,_, it_PRP was_VBD reluctant_JJ to_TO delay_VB
          launching_VBG the_DT programme_NN in_IN order_NN to_TO allow_VB researchers_NNS to_TO
          perform_VB an_DT additional_JJ baseline_NN survey_NN focused_VBN on_IN private_JJ
          prescribing_VBG practices_NNS ._.
          Hence_RB ,_, the_DT study_NN team_NN opted_VBD for_IN a_DT post_NN hoc_FW evaluation_NN ,_,
          recognizing_VBG the_DT limitations_NNS of_IN this_DT design_NN ._. Because_IN it_PRP
          was_VBD not_RB possible_JJ to_TO randomize_NN outlets_NNS ,_, the_DT researchers_NNS
          decided_VBD that_IN "_'' informed_VBN outlets_NNS "_'' would_MD be_VB defined_VBN as_IN
          outlets_NNS that_WDT had_VBD received_VBN the_DT posters_NNS ,_, confirmed_VBD either_CC
          by_IN the_DT presence_NN of_IN a_DT shopkeeper_NN job_NN aid_NN or_CC the_DT respondent_NN
          stating_VBG that_IN it_PRP had_VBD been_VBN received_VBN ._. Outlets_NNP never_RB having_VBG
          received_VBN job_NN aids_NNS would_MD be_VB defined_VBN as_IN controls_NNS ._.
          The_DT study_NN team_NN was_VBD aware_JJ that_WDT informed_VBD and_CC control_NN
          outlets_NNS might_MD differ_VB in_IN ways_NNS that_WDT could_MD affect_VB directly_RB
          the_DT outcomes_NNS of_IN interest_NN ._. To_TO increase_VB internal_JJ validity_NN ,_,
          the_DT team_NN sought_VBN to_TO visit_VB control_NN outlets_NNS that_IN resembled_JJ
          receipted_JJ outlets_NNS in_IN terms_NNS of_IN location_NN ,_, size_NN ,_, and_CC type_NN ._.
          In_IN addition_NN ,_, during_IN data_NNS analysis_NN ,_, the_DT team_NN examined_VBD
          whether_IN the_DT respondent_NN 's_POS position_NN (_( employee_NN ,_, family_NN
          member_NN or_CC owner_NN )_) ,_, educational_JJ level_NN or_CC gender_NN could_MD bias_NN
          results_NNS ._. None_NN of_IN these_DT seemed_VBN to_TO be_VB confounders_NNS ._. A_DT post_NN
          hoc_FW stepwise_NN logistic_JJ regression_NN analysis_NN found_VBD that_IN the_DT
          only_RB variable_JJ predicting_NN whether_IN an_DT outlet_NN was_VBD labeled_VBN
          informed_VBN or_CC control_NN was_VBD its_PRP$ sources_NNS of_IN drugs_NNS (_( informed_VBN
          outlets_NNS were_VBD more_RBR likely_JJ to_TO report_VB purchasing_VBG drugs_NNS from_IN
          mobile_JJ vendors_NNS )_) ._. However_RB ,_, it_PRP is_VBZ not_RB known_VBN if_IN informed_VBN and_CC
          control_NN outlets_NNS differed_VBD in_IN other_JJ ways_NNS not_RB measured_VBN by_IN
          the_DT study_NN team_NN ,_, such_JJ as_IN receptivity_NN to_TO being_VBG educated_VBN by_IN
          a_DT wholesaler_NN ._.
          For_IN locating_VBG informed_VBN outlets_NNS ,_, the_DT team_NN started_VBD with_IN
          the_DT 231_CD receipts_NNS collected_VBN from_IN wholesalers_NNS ._. They_PRP
          discarded_VBD 105_CD for_IN the_DT following_JJ reasons_NNS :_: 10_CD were_VBD
          duplicates_NNS ;_: 19_CD were_VBD schools_NNS or_CC laboratories_NNS ,_, did_VBD not_RB have_VB
          names_NNS or_CC were_VBD outside_IN the_DT district_NN ;_: and_CC 76_CD were_VBD in_IN remote_JJ
          sub-locations_JJ ._. Thus_RB ,_, 126_CD informed_VBN outlets_NNS were_VBD sought_VBN ._. Of_IN
          these_DT ,_, 47_CD (_( 37_CD %_NN )_) were_VBD no_DT longer_RB operational_JJ or_CC could_MD not_RB
          be_VB found_VBN ,_, 9_CD (_( 7_CD %_NN )_) had_VBD never_RB received_VBN the_DT job_NN aids_NNS ,_, and_CC 7_CD
          (_( 5_CD %_NN )_) were_VBD not_RB visited_VBN by_IN one_CD mystery_NN shopper_NN ._. Hence_RB ,_, 63_CD
          of_IN the_DT receipted_JJ outlets_NNS sought_VBN were_VBD characterized_VBN as_IN
          informed_VBN ._. The_DT nine_CD which_WDT did_VBD not_RB receive_VB job_NN aids_NNS were_VBD
          characterized_VBN as_IN controls_NNS ._.
          For_IN control_NN outlets_NNS ,_, the_DT strategy_NN was_VBD to_TO select_VB one_CD to_TO
          two_CD drug_NN outlets_NNS near_IN the_DT receipted_JJ outlets_NNS ,_, as_RB well_RB as_IN
          15_CD outlets_NNS from_IN a_DT neighbouring_VBG district_NN (_( Teso_NNP )_) ._. Of_IN the_DT
          approximately_RB 200_CD non-receipted_JJ outlets_NNS visited_VBD ,_, 20_CD (_( 10_CD %_NN )_)
          did_VBD not_RB have_VB anti-malarials_JJ in_IN stock_NN ,_, 38_CD (_( 19_CD %_NN )_) had_VBD
          received_VBN job_NN aids_NNS and_CC were_VBD labeled_VBN informed_VBN outlets_NNS and_CC
          142_CD (_( 72_CD %_NN )_) never_RB received_VBD job_NN aids_NNS and_CC were_VBD labeled_VBN
          controls_NNS ._. In_IN all_DT ,_, 101_CD informed_VBN and_CC 151_CD control_NN outlets_NNS
          were_VBD obtained_VBN ._.
        
        
          Data_NNP analysis_NN
          Data_NNP entry_NN and_CC statistical_JJ analysis_NN was_VBD conducted_VBN
          using_VBG SPSS_NNP 8_CD ._. 0_CD ._. Chi-square_NNP ,_, ANOVA_NNP ,_, and_CC logistic_JJ
          regression_NN were_VBD performed_VBN to_TO compare_VB informed_VBN versus_CC
          control_NN outlets_NNS ,_, to_TO examine_VB the_DT potential_JJ impact_NN of_IN
          confounders_NNS and_CC to_TO check_VB for_IN differences_NNS by_IN mystery_NN
          shopper_NN scenario_NN ._.
        
      
      
        Results_NNS
        
          Profile_NNP of_IN private_JJ outlets_NNS ,_, drugs_NNS and_CC prices_NNS
          
            Private_JJ drug_NN outlets_NNS
            More_JJR than_IN half_NN of_IN the_DT attendants_NNS at_IN the_DT 252_CD retail_JJ
            outlets_NNS interviewed_VBN by_IN supervisors_NNS were_VBD female_JJ and_CC
            about_IN 42_CD %_NN were_VBD the_DT owners_NNS (_( see_VB Table_NNP 1_LS )_) ._. Nearly_RB 25_CD %_NN had_VBD
            eight_CD years_NNS or_CC less_JJR of_IN education_NN ._. About_IN 75_CD %_NN of_IN these_DT
            outlets_NNS were_VBD shops_NNS or_CC kiosks_NNS ,_, and_CC 58_CD %_NN were_VBD in_IN rural_JJ
            areas_NNS ._. Outlets_NNP reported_VBD serving_VBG nine_CD malaria_NN clients_NNS on_IN
            average_JJ per_IN day_NN (_( range_NN :_: one_CD to_TO 120_CD )_) ,_, of_IN whom_WP half_NN were_VBD
            children_NNS under_IN five_CD ._. About_IN 20_CD %_NN of_IN these_DT outlets_NNS
            obtained_VBD anti-malarial_JJ drugs_NNS from_IN mobile_JJ vendors_NNS ._.
            Informed_NNP and_CC control_NN outlets_NNS were_VBD similar_JJ in_IN terms_NNS
            of_IN sex_NN and_CC education_NN level_NN of_IN attendants_NNS ,_, as_RB well_RB as_IN
            setting_VBG ._. Informed_NNP outlets_NNS were_VBD more_RBR likely_JJ to_TO be_VB
            pharmacies_NNS ,_, but_CC they_PRP did_VBD not_RB have_VB a_DT significantly_RB
            larger_JJR clientele_NNS on_IN average_JJ than_IN control_NN outlets_NNS ._.
            Informed_NNP outlets_NNS were_VBD also_RB more_RBR likely_JJ to_TO purchase_VB
            their_PRP$ drugs_NNS from_IN wholesale_JJ pharmacies_NNS and_CC mobile_JJ
            vendors_NNS ._. About_IN 27_CD %_NN of_IN informed_VBN outlets_NNS reported_VBD getting_VBG
            job_NN aids_NNS from_IN wholesale_JJ attendants_NNS ,_, 51_CD %_NN from_IN mobile_JJ
            vendors_NNS ,_, and_CC 22_CD %_NN did_VBD not_RB know_VB who_WP supplied_VBD them_PRP ._.
          
          
            Drugs_NNS available_JJ
            More_JJR than_IN 70_CD different_JJ brands_NNS of_IN various_JJ
            anti-malarial_JJ drugs_NNS and_CC over_IN 30_CD brands_NNS of_IN anti-pyretics_JJ
            were_VBD found_VBN in_IN the_DT outlets_NNS visited_VBD ._. This_DT represents_VBZ a_DT
            significant_JJ increase_NN from_IN 17_CD brands_NNS of_IN anti-malarials_JJ
            found_VBD in_IN Kenya_NNP in_IN 1995_CD [_NN 7_CD ]_NN ._. On_IN average_JJ ,_, pharmacies_NNS
            had_VBD 10_CD different_JJ brands_NNS of_IN various_JJ anti-malarials_JJ in_IN
            stock_NN ,_, while_IN shops_NNS had_VBD two_CD and_CC private_JJ clinics_NNS five_CD ._.
            Amodiaquine_NNP (_( AQ_NNP )_) ,_, the_DT second-line_JJ drug_NN ,_, was_VBD the_DT most_RBS
            frequently_RB stocked_VBN (_( see_VB Table_NNP 2_LS )_) ._. Of_IN outlets_NNS visited_VBD ,_,
            81_CD %_NN stocked_VBN AQ_NNP ,_, while_IN only_RB 39_CD %_NN stocked_VBN SP_NNP and_CC 41_CD %_NN
            stocked_VBN chloroquine_NN (_( CQ_NNP )_) ._. Drug_NNP stocking_VBG and_CC source_NN of_IN
            drugs_NNS were_VBD found_VBN to_TO differ_VB significantly_RB by_IN type_NN of_IN
            outlet_NN ._. About_IN 60_CD %_NN of_IN shops_NNS /_NN kiosks_NNS bought_VBN drugs_NNS from_IN
            wholesale_JJ general_JJ shops_NNS ,_, which_WDT only_RB stock_NN
            over-the-counter_JJ drugs_NNS ._. In_IN contrast_NN ,_, almost_RB all_DT
            pharmacies_NNS /_NN chemists_NNS and_CC private_JJ clinics_NNS obtained_VBD their_PRP$
            drugs_NNS from_IN large_JJ wholesale_JJ pharmacies_NNS ._. Mobile_NNP vendors_NNS
            sold_VBN mainly_RB to_TO rural_JJ shops_NNS and_CC kiosks_NNS ._.
          
          
            Drugs_NNS sold_VBN to_TO mystery_NN shoppers_NNS
            Not_RB only_RB was_VBD AQ_NNP the_DT most_RBS stocked_VBN anti-malarial_JJ ,_, it_PRP
            was_VBD also_RB sold_VBN most_RBS frequently_RB to_TO mystery_NN shoppers_NNS (_( see_VB
            Table_NNP 3_LS )_) ._. SP_NNP was_VBD sold_VBN to_TO less_JJR than_IN 15_CD %_NN of_IN mystery_NN
            shoppers_NNS ,_, about_IN the_DT same_JJ proportion_NN who_WP were_VBD sold_VBN CQ_NNP ._.
            Mystery_NNP shoppers_NNS were_VBD never_RB sold_VBN injectables_NNS and_CC very_RB
            few_JJ were_VBD sold_VBN combinations_NNS of_IN anti-malarial_JJ drugs_NNS ._.
            About_IN 5_CD %_NN of_IN shoppers_NNS were_VBD sold_VBN antibiotics_NNS ,_,
            anti-pyretics_JJ or_CC other_JJ drugs_NNS as_IN anti-malarials_JJ ._. Nine_CD
            mystery_NN shoppers_NNS (_( 2_CD %_NN )_) were_VBD sold_VBN drugs_NNS that_WDT were_VBD not_RB
            genuine_JJ ._. In_IN 29_CD %_NN of_IN visits_NNS ,_, the_DT outlet_NN refused_VBD to_TO sell_VB
            any_DT drug_NN ,_, probably_RB due_JJ to_TO concerns_NNS by_IN shopkeepers_NNS about_IN
            the_DT legality_NN of_IN selling_VBG drugs_NNS for_IN young_JJ children_NNS ._.
            Refusal_NNP to_TO sell_VB drugs_NNS differed_VBD significantly_RB by_IN child_NN 's_POS
            age_NN and_CC outlet_NN type_NN :_: 43_CD %_NN of_IN shops_NNS versus_CC 3_CD %_NN of_IN
            pharmacies_NNS would_MD not_RB sell_VB anti-malarial_JJ drugs_NNS for_IN a_DT
            9_CD -_: month_NN old_JJ child_NN ,_, whereas_IN 26_CD %_NN of_IN shops_NNS versus_CC 2_CD %_NN of_IN
            pharmacies_NNS would_MD not_RB sell_VB for_IN a_DT 2_CD -_: year-old_JJ child_NN ._.
            Whether_IN shoppers_NNS were_VBD told_VBN the_DT correct_JJ dose_NN differed_VBD
            significantly_RB by_IN type_NN of_IN drug_NN ._. Shoppers_NNS who_WP were_VBD sold_VBN
            SP_NNP were_VBD much_RB more_RBR likely_JJ to_TO be_VB told_VBN the_DT correct_JJ dose_NN
            (_( 76_CD %_NN )_) than_IN those_DT sold_VBN AQ_NNP (_( 26_CD %_NN )_) or_CC CQ_NNP (_( 7_CD %_NN )_) ._. The_DT fact_NN
            that_IN SP_NNP is_VBZ a_DT single_JJ dose_NN treatment_NN may_MD have_VB made_VBN it_PRP
            easier_JJR for_IN attendants_NNS to_TO remember_VB ._. Many_JJ attendants_NNS
            mistakenly_RB recommended_VBD a_DT single_JJ dose_NN of_IN AQ_NNP instead_RB of_IN
            the_DT required_JJ three-day_JJ treatment_NN ._.
          
          
            Drug_NN prices_NNS
            The_DT prices_NNS paid_VBN by_IN the_DT mystery_NN shoppers_NNS for_IN treating_VBG
            their_PRP$ child_NN 's_POS malaria_NN as_IN recommended_VBN by_IN outlet_NN
            attendants_NNS varied_VBD widely_RB ,_, from_IN about_IN $_$ 0_CD ._. 03_CD to_TO $_$ 2_CD ._. 29_CD ._.
            These_DT prices_NNS included_VBD anti-pyretics_JJ ._. On_IN average_NN ,_, the_DT
            price_NN per_IN tablet_NN was_VBD $_$ 0_CD ._. 10_CD ,_, whereas_IN the_DT price_NN per_IN
            bottle_NN of_IN syrup_NN was_VBD $_$ 0_CD ._. 81_CD ._. The_DT price_NN within_IN drug_NN brands_NNS
            also_RB varied_VBD ._. For_IN example_NN ,_, one_CD tablet_NN of_IN Malaratab_NNP (_( the_DT
            most_RBS popular_JJ AQ_NNP )_) ranged_VBD from_IN $_$ ._. 07_CD to_TO $_$ ._. 21_CD ._. Profit_NN
            margins_NNS may_MD provide_VB a_DT motive_NN for_IN why_WRB AQ_NNP was_VBD sold_VBN so_RB
            frequently_RB ._. In_IN general_JJ ,_, AQ_NNP drugs_NNS had_VBD higher_JJR profit_NN
            margins_NNS than_IN SP_NNP drugs_NNS ,_, and_CC syrups_NNS had_VBD higher_JJR profit_NN
            margins_NNS than_IN tablets_NNS ._. Average_JJ profits_NNS for_IN a_DT full_JJ child_NN
            dose_NN ranged_VBD from_IN $_$ ._. 03_CD for_IN Fansidar_NNP tablets_NNS (_( SP_NNP )_) to_TO $_$ ._. 34_CD
            for_IN Malaramed_NNP syrup_NN (_( AQ_NNP )_) ._.
          
        
        
          Coverage_NNP and_CC acceptability_NN
          
            Coverage_NNP
            During_IN the_DT training_NN ,_, about_IN 1400_CD copies_NNS of_IN each_DT
            poster_NN were_VBD distributed_VBN to_TO the_DT wholesale_JJ attendants_NNS and_CC
            mobile_JJ vendors_NNS for_IN dissemination_NN ._. Based_VBN on_IN the_DT receipts_NNS
            collected_VBN and_CC the_DT proportion_NN of_IN unreceipted_JJ informed_VBN
            outlets_NNS found_VBD during_IN the_DT study_NN ,_, it_PRP is_VBZ estimated_VBN that_IN in_IN
            six_CD months_NNS about_IN 450_CD to_TO 500_CD private_JJ drug_NN outlets_NNS were_VBD
            reached_VBN ,_, with_IN minimal_JJ effort_NN from_IN the_DT DHMT_NNP ._.
          
          
            Job_NNP aids_NNS acceptability_NN ,_, visibility_NN and_CC use_NN
            About_IN 63_CD %_NN of_IN the_DT informed_VBN outlets_NNS were_VBD displaying_VBG
            the_DT shopkeeper_NN job_NN aid_NN and_CC the_DT client_NN poster_NN at_IN the_DT
            time_NN of_IN the_DT supervisor_NN 's_POS visit_NN ._. The_DT majority_NN of_IN the_DT
            shopkeeper_NN job_NN aids_NNS were_VBD displayed_VBN in_IN a_DT visible_JJ
            location_NN ,_, such_JJ as_IN on_IN a_DT wall_NN ._. About_IN 62_CD %_NN of_IN retail_JJ
            attendants_NNS said_VBD they_PRP used_VBD the_DT shopkeeper_NN job_NN aid_NN ,_, and_CC
            47_CD %_NN believed_VBD clients_NNS used_VBD the_DT client_NN poster_NN ._. An_DT
            indication_NN of_IN the_DT usefulness_NN of_IN the_DT shopkeeper_NN job_NN aid_NN
            was_VBD that_IN 31_CD %_NN of_IN informed_VBN outlets_NNS spontaneously_RB used_VBN it_PRP
            when_WRB asked_VBD about_IN dosages_NNS of_IN SP_NNP drugs_NNS ._.
          
        
        
          Impact_NNP of_IN programme_NN
          
            Knowledge_NNP of_IN correct_JJ malaria_NN treatment_NN
            During_IN the_DT evaluation_NN the_DT supervisors_NNS administered_VBN a_DT
            ten-question_JJ malaria_NN knowledge_NN quiz_NN ._. Informed_NNP outlets_NNS
            scored_VBD significantly_RB better_JJR than_IN control_NN outlets_NNS on_IN
            seven_CD out_IN of_IN ten_CD questions_NNS ,_, and_CC slightly_RB better_JJR or_CC
            equivalent_NN on_IN the_DT rest_NN ._. Informed_NNP outlets_NNS had_VBD better_JJR
            knowledge_NN of_IN important_JJ concepts_NNS ,_, such_JJ as_IN that_DT SP_NNP is_VBZ not_RB
            too_RB strong_JJ for_IN children_NNS and_CC that_IN SP_NNP can_MD be_VB sold_VBN in_IN
            shops_NNS ._. Among_IN outlets_NNS that_WDT stocked_VBN SP_NNP ,_, 76_CD %_NN of_IN informed_VBN
            outlets_NNS (_( 48_CD /_NN 63_CD )_) knew_VBD the_DT correct_JJ dose_NN of_IN SP_NNP for_IN an_DT
            18_CD -_: month-old_JJ child_NN ,_, as_IN compared_VBN to_TO 43_CD %_NN of_IN controls_NNS
            (_( 15_CD /_NN 35_CD )_) (_( chi-square_JJ =_SYM 10_CD ._. 9_CD ,_, p_NN <_NN ._. 001_CD )_) ._.
            A_DT total_JJ knowledge_NN score_NN was_VBD calculated_VBN by_IN assigning_VBG
            one_CD point_NN to_TO a_DT correct_JJ answer_NN and_CC zero_CD points_NNS for_IN an_DT
            incorrect_JJ answer_NN or_CC "_'' do_VBP n't_RB know_VB "_'' ._. Informed_NNP outlets_NNS
            scored_VBD 8_CD ._. 7_CD (_( out_IN of_IN 10_CD )_) on_IN average_JJ while_IN control_NN outlets_NNS
            scored_VBD 7_CD ._. 1_CD ._. Informed_NNP outlets_NNS receiving_VBG job_NN aids_NNS from_IN
            mobile_JJ vendors_NNS had_VBD significantly_RB higher_JJR scores_NNS than_IN
            those_DT receiving_VBG job_NN aids_NNS from_IN wholesale_JJ attendants_NNS (_( 9_CD ._. 2_LS
            vs_NNS ._. 8_CD ._. 6_CD )_) ._. Analysis_NNP by_IN education_NN level_NN revealed_VBD that_IN ,_, at_IN
            each_DT level_NN ,_, informed_VBN outlets_NNS scored_VBD higher_JJR ._. When_WRB
            compared_VBN by_IN outlet_NN type_NN ,_, the_DT intervention_NN appears_VBZ to_TO
            have_VB had_VBD a_DT significant_JJ impact_NN on_IN shops_NNS '_POS and_CC pharmacies_NNS '_POS
            knowledge_NN ,_, but_CC not_RB private_JJ clinics_NNS (_( see_VB Table_NNP 4_LS )_) ._.
          
          
            Stocking_NNP of_IN drugs_NNS
            As_IN shown_VBN in_IN Table_NNP 2_CD ,_, informed_VBN outlets_NNS were_VBD
            significantly_RB more_RBR likely_JJ to_TO stock_VB SP_NNP than_IN control_NN
            outlets_NNS (_( 62_CD %_NN vs_NNS ._. 23_CD %_NN )_) ._. Shops_NNS mainly_RB accounted_VBD for_IN the_DT
            striking_JJ difference_NN in_IN SP_NNP stocking_VBG ._. Overall_RB ,_, there_EX was_VBD
            no_DT significant_JJ difference_NN in_IN stocking_NN of_IN AQ_NNP ._. Informed_NNP
            shops_NNS were_VBD significantly_RB less_RBR likely_JJ than_IN control_NN shops_NNS
            to_TO stock_VB CQ_NNP (_( 22_CD %_NN vs_NNS ._. 42_CD %_NN )_) ,_, as_IN were_VBD informed_VBN clinics_NNS
            relative_JJ to_TO control_VB clinics_NNS (_( 0_CD %_NN vs_NNS ._. 54_CD %_NN )_) ._.
          
          
            Dispensing_NNP practices_NNS
            The_DT key_JJ malaria_NN dispensing_VBG practice_NN is_VBZ selling_VBG an_DT
            approved_VBD first-line_JJ anti-malarial_JJ ._. The_DT Kenya_NNP National_NNP
            Malaria_NNP Guidelines_NNS state_VBP that_IN SP_NNP is_VBZ the_DT first-line_JJ drug_NN
            for_IN uncomplicated_JJ malaria_NN in_IN all_DT age_NN groups_NNS and_CC should_MD
            be_VB taken_VBN with_IN an_DT anti-pyretic_JJ ._. As_IN shown_VBN in_IN Table_NNP 5_CD ,_, the_DT
            intervention_NN seems_VBZ to_TO have_VB had_VBD a_DT differential_NN impact_NN by_IN
            outlet_NN type_NN ._. Of_IN those_DT mystery_NN shoppers_NNS who_WP went_VBD to_TO
            shops_NNS /_NN kiosks_NNS ,_, 32_CD %_NN visiting_VBG informed_VBN outlets_NNS were_VBD sold_VBN
            SP_NNP ,_, compared_VBN to_TO only_RB 5_CD %_NN at_IN control_NN outlets_NNS (_( p_NN <_NN
            ._. 000_CD )_) ._. There_EX was_VBD no_DT significant_JJ differences_NNS in_IN the_DT
            other_JJ outlet_NN types_NNS ._. Among_IN the_DT informed_VBN outlets_NNS ,_, those_DT
            receiving_VBG job_NN aids_NNS from_IN mobile_JJ vendors_NNS were_VBD
            significantly_RB more_RBR likely_JJ to_TO sell_VB correct_JJ drugs_NNS than_IN
            those_DT who_WP received_VBD aids_NNS from_IN wholesale_JJ attendants_NNS (_( 29_CD %_NN
            vs_NNS ._. 7_CD %_NN )_) ._.
            Explicit_NNP consumer_NN demand_NN appeared_VBD to_TO have_VB an_DT impact_NN ._.
            Overall_RB ,_, 9_CD %_NN of_IN female_JJ shoppers_NNS (_( who_WP did_VBD not_RB demand_VB CQ_NNP )_)
            were_VBD sold_VBN a_DT CQ-based_NNP drug_NN ,_, compared_VBN to_TO 21_CD %_NN of_IN male_JJ
            shoppers_NNS (_( who_WP did_VBD demand_NN CQ_NNP )_) ._. If_IN more_JJR than_IN 40_CD %_NN of_IN
            outlets_NNS had_VBD stocked_VBN CQ_NNP ,_, the_DT demand_NN effect_NN might_MD have_VB
            been_VBN higher_JJR ._. Controls_NNP were_VBD twice_RB as_RB likely_JJ as_IN informed_VBN
            outlets_NNS to_TO sell_VB CQ-based_NNP drugs_NNS to_TO mystery_NN shoppers_NNS (_( see_VB
            Table_NNP 5_LS )_) ._.
            Of_IN all_DT shoppers_NNS who_WP were_VBD sold_VBN a_DT drug_NN ,_, 24_CD %_NN (_( 37_CD /_NN 157_CD )_)
            purchased_VBD an_DT approved_VBD SP_NNP and_CC an_DT anti-pyretic_JJ at_IN
            informed_VBN outlets_NNS ,_, as_IN compared_VBN to_TO only_RB 3_CD %_NN (_( 6_CD /_NN 202_CD )_) at_IN
            control_NN outlets_NNS ._. More_RBR than_IN twice_RB as_IN many_JJ mystery_NN
            shoppers_NNS were_VBD told_VBN the_DT correct_JJ dose_NN by_IN informed_VBN outlets_NNS
            (_( 38_CD %_NN )_) than_IN by_IN control_NN outlets_NNS (_( 15_CD %_NN )_) ._. All_DT told_VBD ,_, 17_CD %_NN of_IN
            shoppers_NNS who_WP purchased_VBD drugs_NNS at_IN informed_VBN outlets_NNS both_DT
            received_VBD an_DT approved_VBN drug_NN and_CC were_VBD told_VBN the_DT correct_JJ
            dose_NN ,_, as_IN compared_VBN to_TO only_RB 2_CD %_NN at_IN control_NN outlets_NNS (_( p_NN <_NN
            ._. 001_CD )_) ._.
            To_TO provide_VB effective_JJ malaria_NN treatment_NN the_DT drug_NN
            seller_NN should_MD ask_VB several_JJ diagnostic_JJ questions_NNS ._. In_IN
            comparing_VBG informed_VBN to_TO control_VB outlets_NNS ,_, 92_CD %_NN vs_NNS ._. 85_CD %_NN
            inquired_VBD about_IN the_DT child_NN 's_POS age_NN ,_, 50_CD %_NN vs_NNS ._. 30_CD %_NN asked_VBD about_IN
            symptoms_NNS ,_, and_CC 21_CD %_NN vs_NNS ._. 11_CD %_NN about_IN the_DT duration_NN of_IN
            illness_NN ._. All_DT of_IN these_DT differences_NNS were_VBD statistically_RB
            significant_JJ (_( p_NN <_NN ._. 001_CD )_) ._. Significantly_RB more_RBR informed_JJ
            outlets_NNS (_( 24_CD %_NN )_) than_IN control_NN outlets_NNS (_( 13_CD %_NN )_) told_VBD the_DT
            mystery_NN shopper_NN what_WP to_TO do_VB if_IN a_DT child_NN 's_POS health_NN
            worsens_NNS ._.
          
        
      
      
        Discussion_NNP
        In_IN areas_NNS with_IN a_DT high_JJ transmission_NN of_IN malaria_NN ,_, adverse_JJ
        outcomes_NNS from_IN malaria_NN can_MD only_RB be_VB reduced_VBN if_IN malaria_NN
        symptoms_NNS are_VBP recognized_VBN early_JJ (_( within_IN the_DT first_JJ 12_CD -_: 18_CD hours_NNS
        after_IN onset_NN )_) and_CC sick_JJ children_NNS are_VBP treated_VBN promptly_RB with_IN
        effective_JJ anti-malarial_JJ drugs_NNS in_IN the_DT right_JJ doses_NNS ._. Public_JJ
        education_NN campaigns_NNS on_IN malaria_NN symptoms_NNS and_CC the_DT importance_NN
        of_IN prompt_VB and_CC effective_JJ treatment_NN are_VBP vital_JJ ._. Yet_RB these_DT
        campaigns_NNS will_MD be_VB of_IN limited_JJ value_NN if_IN consumers_NNS are_VBP sold_VBN
        ineffective_JJ drugs_NNS in_IN the_DT wrong_JJ doses_NNS ._. For_IN this_DT reason_NN ,_,
        strengthening_VBG the_DT capacity_NN of_IN private_JJ drug_NN outlets_NNS to_TO
        provide_VB the_DT recommended_VBD anti-malarial_JJ drugs_NNS and_CC information_NN
        is_VBZ important_JJ ._. The_DT challenge_NN is_VBZ to_TO achieve_VB greater_JJR
        performance_NN of_IN private_JJ outlets_NNS at_IN a_DT cost_NN low_JJ enough_RB for_IN the_DT
        activity_NN to_TO be_VB scaled_VBN up_RP nationally_RB ._.
        Four_CD strategies_NNS have_VBP been_VBN advanced_VBN for_IN improving_VBG the_DT
        practices_NNS of_IN retail_JJ pharmacies_NNS in_IN developing_VBG countries_NNS :_:
        information_NN ,_, persuasion_NN ,_, incentives_NNS and_CC coercion_NN [_NN 13_CD ]_NN ._.
        To_TO date_NN ,_, very_RB few_JJ interventions_NNS to_TO change_VB retailer_NN
        behaviours_NNS through_IN persuasion_NN (_( or_CC any_DT other_JJ means_VBZ )_) have_VBP
        been_VBN systematically_RB introduced_VBN and_CC evaluated_VBN [_NN 14_CD ]_NN ._. One_CD
        intervention_NN for_IN pharmacy_NN attendants_NNS in_IN Kenya_NNP and_CC
        Indonesia_NNP ,_, called_VBN "_'' face_NN to_TO face_VB educational_JJ outreach_NN ,_, "_''
        resulted_VBD in_IN significant_JJ short-term_JJ improvements_NNS in_IN
        diarrhoeal_NN product_NN sales_NNS and_CC communication_NN with_IN customers_NNS
        on_IN diarrhoea_NN treatment_NN [_NN 15_CD ]_NN ._. Other_JJ studies_NNS have_VBP
        indicated_VBN that_IN job_NN aids_NNS tailored_VBN to_TO the_DT needs_NNS of_IN the_DT target_NN
        audience_NN can_MD positively_RB affect_VB performance_NN [_NN 16_CD ]_NN ._.
        The_DT vendor-to-vendor_JJ programme_NN combined_VBD the_DT strategies_NNS
        of_IN persuasion_NN and_CC customized_VBN information_NN to_TO achieve_VB
        improved_VBN knowledge_NN and_CC dispensing_VBG practices_NNS among_IN all_DT
        private_JJ retailers_NNS ._. Prior_RB research_NN by_IN the_DT DHMT_NNP had_VBD revealed_VBN
        that_IN wholesalers_NNS were_VBD considered_VBN credible_JJ sources_NNS of_IN drug_NN
        information_NN for_IN retailers_NNS ._. Hence_RB ,_, they_PRP were_VBD designated_VBN as_RB
        the_DT "_'' persuaders_NNS ._. "_'' Informal_NNP interviews_NNS indicated_VBD that_IN the_DT
        mobile_JJ vendors_NNS were_VBD more_RBR enthusiastic_JJ distributors_NNS of_IN the_DT
        job_NN aids_NNS than_IN were_VBD the_DT wholesale_JJ attendants_NNS ,_, largely_RB
        because_IN being_VBG involved_VBN in_IN the_DT programme_NN apparently_RB
        heightened_VBD their_PRP$ status_NN ._. Also_RB ,_, since_IN they_PRP were_VBD not_RB facing_VBG
        queues_NNS of_IN retailers_NNS ,_, communicating_VBG the_DT guidelines_NNS was_VBD more_RBR
        feasible_JJ for_IN mobile_JJ vendors_NNS ._.
        The_DT main_JJ alternate_JJ model_NN for_IN changing_VBG shopkeeper_NN
        anti-malarial_JJ dispensing_VBG behaviours_NNS has_VBZ been_VBN piloted_JJ in_IN
        Kilifi_NNP ,_, Kenya_NNP ._. The_DT model_NN consisted_VBD of_IN a_DT series_NN of_IN three_CD
        workshops_NNS ,_, each_DT lasting_JJ for_IN three_CD days_NNS ,_, followed_VBN by_IN a_DT
        two-day_JJ refresher_NN training_NN ._. The_DT activity_NN seems_VBZ to_TO have_VB led_VBN
        to_TO dramatic_JJ improvements_NNS in_IN CQ_NNP prescribing_VBG practices_NNS among_IN
        a_DT limited_JJ number_NN of_IN shops_NNS [_NN 17_CD ]_NN ._. But_CC due_JJ to_TO the_DT high_JJ
        turn-over_JJ among_IN employees_NNS and_CC the_DT shortlife_NN spans_NNS of_IN many_JJ
        outlets_NNS ,_, this_DT model_NN would_MD require_VB constant_JJ identification_NN
        and_CC training_NN ,_, which_WDT could_MD be_VB onerous_JJ for_IN districts_NNS ._.
        Furthermore_RB ,_, the_DT Kilifi_NNP approach_NN does_VBZ not_RB involve_VB the_DT
        wholesale_JJ distributors_NNS ,_, who_WP seem_VBP to_TO play_VB a_DT key_JJ role_NN in_IN
        influencing_VBG drug_NN purchasing_NN and_CC prescribing_VBG practices_NNS ._.
        While_IN the_DT vendor-to-vendor_JJ programme_NN did_VBD seem_VB to_TO improve_VB
        shops_NNS '_POS knowledge_NN and_CC behaviour_NN in_IN a_DT relatively_RB short_JJ time_NN ,_,
        the_DT gap_NN between_IN actual_JJ and_CC desired_VBN performance_NN was_VBD still_RB
        depressingly_RB large_JJ ._. This_DT could_MD be_VB due_JJ to_TO several_JJ factors_NNS ._.
        First_LS ,_, informed_VBN outlets_NNS still_RB had_VBD stocks_NNS of_IN old_JJ drugs_NNS that_IN
        they_PRP needed_VBD to_TO sell_VB ._. Virtually_RB all_DT drug_NN outlets_NNS operate_VBP on_IN
        very_RB limited_JJ budgets_NNS and_CC cannot_NN afford_VB to_TO discard_VB drugs_NNS
        that_WDT are_VBP no_RB longer_RB recommended_VBD ._. Second_JJ ,_, confusion_NN and_CC fear_NN
        about_IN SP_NNP were_VBD common_JJ in_IN the_DT district_NN ._. Many_JJ outlets_NNS still_RB
        were_VBD not_RB sure_JJ whether_IN they_PRP were_VBD indeed_RB entitled_VBN to_TO sell_VB SP_NNP
        over-the-counter_NN ._. Also_RB ,_, nearly_RB half_NN still_RB believed_VBD that_IN SP_NNP
        was_VBD too_RB strong_JJ for_IN chldren_NN ._. Third_NNP ,_, the_DT programme_NN did_VBD not_RB
        address_VB the_DT use_NN of_IN AQ_NNP ,_, which_WDT had_VBD become_VBN extremely_RB popular_JJ
        in_IN the_DT district_NN due_JJ to_TO extensive_JJ advertising_NN ,_, high_JJ profit_NN
        margins_NNS for_IN sellers_NNS ,_, and_CC an_DT apparently_RB cheaper_JJR price_NN for_IN
        consumers_NNS than_IN SP_NNP due_JJ to_TO misleading_JJ packaging_NN ._. It_PRP seems_VBZ
        likely_JJ that_IN the_DT main_JJ reason_NN that_IN the_DT programme_NN did_VBD not_RB
        significantly_RB affect_VB pharmacists_NNS relates_VBZ to_TO the_DT large_JJ
        profit_NN margins_NNS on_IN AQ_NNP syrups_NNS ,_, which_WDT were_VBD only_RB available_JJ in_IN
        pharmacies_NNS ._. For_IN the_DT vendor-to-vendor_JJ programme_NN to_TO have_VB a_DT
        substantial_JJ rather_RB than_IN a_DT limited_JJ impact_NN ,_, these_DT issues_NNS
        would_MD need_VB to_TO be_VB addressed_VBN ._.
        Affordability_NNP is_VBZ a_DT critical_JJ issue_NN for_IN scaling_VBG up_RP ._. The_DT
        vendor-to-vendor_JJ model_NN can_MD be_VB considered_VBN "_'' high_JJ quantity_NN "_''
        (_( wide_JJ coverage_NN )_) and_CC "_'' moderate_JJ quality_NN "_'' (_( significant_JJ but_CC
        limited_JJ improvements_NNS )_) at_IN low_JJ cost_NN (_( about_IN $_$ 40_CD per_IN wholesale_JJ
        outlet_NN reached_VBN -_: including_VBG mobile_JJ vendors_NNS -_: and_CC about_RB $_$ 9_CD -_: 11_CD
        per_IN retail_JJ outlet_NN reached_VBN )_) ._. To_TO help_VB other_JJ districts_NNS to_TO
        launch_VB the_DT activity_NN on_IN their_PRP$ own_JJ ,_, the_DT Quality_NNP Assurance_NNP
        Project_NNP has_VBZ produced_VBN a_DT comprehensive_JJ how-to_JJ manual_JJ for_IN
        district_NN managers_NNS interested_VBN in_IN introducing_VBG the_DT
        vendor-to-vendor_JJ programme_NN in_IN their_PRP$ districts_NNS ._. (_( The_DT manual_JJ
        can_MD be_VB downloaded_JJ from_IN the_DT QAP_NNP website_NN ,_,
        http_NN :_: /_NN /_NN www_NN ._. qaproject_NN ._. org_NN ._. )_)
        It_PRP should_MD be_VB noted_VBN that_IN the_DT evaluation_NN had_VBD some_DT serious_JJ
        limitations_NNS ,_, mostly_RB related_VBN to_TO the_DT sampling_VBG design_NN ._.
        Informed_NNP and_CC control_NN outlets_NNS might_MD have_VB differed_VBD in_IN
        important_JJ ways_NNS that_WDT were_VBD not_RB measured_VBN but_CC could_MD affect_VB the_DT
        outcomes_NNS presented_VBN ._. Informed_NNP outlets_NNS may_MD have_VB been_VBN
        "_'' self-selected_JJ "_'' ;_: i_NNP ._. e_SYM ._. ,_, control_NN outlets_NNS may_MD have_VB been_VBN
        offered_VBN job_NN aids_NNS but_CC refused_VBD them_PRP ._.
        Another_DT form_NN of_IN selection_NN bias_NN may_MD have_VB resulted_VBN from_IN
        the_DT decision_NN to_TO exclude_VB receipted_JJ outlets_NNS in_IN remote_JJ
        locations_NNS due_JJ to_TO logistical_JJ considerations_NNS ._. Moreover_RB ,_,
        because_IN outlets_NNS were_VBD not_RB randomly_RB selected_VBN ,_, one_CD cannot_NN
        extrapolate_NN from_IN the_DT study_NN to_TO estimate_VB the_DT percent_NN of_IN all_DT
        outlets_NNS in_IN Bungoma_NNP district_NN stocking_VBG SPs_NNP or_CC giving_VBG correct_JJ
        advice_NN to_TO customers_NNS ._. Hence_RB ,_, additional_JJ studies_NNS of_IN the_DT
        programme_NN are_VBP needed_VBN to_TO validate_NN the_DT findings_NNS ._.
        Using_VBG mystery_NN shoppers_NNS yielded_VBD important_JJ information_NN ,_,
        but_CC it_PRP also_RB had_VBD some_DT drawbacks_NNS ._. Mystery_NNP shoppers_NNS cannot_NN
        evaluate_VB institutions_NNS where_WRB they_PRP would_MD be_VB detected_VBN as_IN
        outsiders_NNS (_( e_SYM ._. g_SYM ._. ,_, school_NN dispensaries_NNS )_) or_CC where_WRB they_PRP are_VBP
        required_VBN to_TO bring_VB their_PRP$ child_NN with_IN them_PRP (_( e_SYM ._. g_SYM ._. ,_, some_DT private_JJ
        clinics_NNS )_) ._. If_IN the_DT mystery_NN shoppers_NNS had_VBD brought_VBN sick_JJ
        children_NNS ,_, private_JJ clinics_NNS probably_RB would_MD have_VB dispensed_VBD
        more_JJR injections_NNS ._. It_PRP is_VBZ also_RB possible_JJ that_IN real_JJ clients_NNS ,_, who_WP
        are_VBP familiar_JJ to_TO the_DT shopkeepers_NNS ,_, would_MD be_VB refused_VBN treatment_NN
        less_RBR often_RB than_IN unknown_JJ clients_NNS (_( mystery_NN shoppers_NNS )_) ._.
      
      
        Conclusions_NNP
        The_DT vendor-to-vendor_JJ programme_NN ,_, a_DT low-cost_JJ outreach_NN
        education_NN strategy_NN ,_, seems_VBZ to_TO have_VB had_VBD a_DT moderate_JJ impact_NN on_IN
        private_JJ drug_NN outlets_NNS '_POS knowledge_NN of_IN and_CC compliance_NN with_IN
        malaria_NN treatment_NN guidelines_NNS in_IN a_DT rural_JJ district_NN of_IN Kenya_NNP ._.
        Given_VBN the_DT difficulty_NN of_IN changing_VBG private_JJ sector_NN practices_NNS ,_,
        the_DT DHMT_NNP found_VBD the_DT results_NNS encouraging_VBG ._. Significant_JJ
        differences_NNS were_VBD observed_VBN between_IN informed_VBN and_CC control_NN
        outlets_NNS on_IN types_NNS and_CC brands_NNS of_IN drugs_NNS sold_VBN ,_, dosages_NNS sold_VBN ,_,
        questions_NNS asked_VBD of_IN clients_NNS ,_, and_CC advice_NN given_VBN ._. The_DT programme_NN
        has_VBZ also_RB had_VBD a_DT positive_JJ impact_NN on_IN knowledge_NN of_IN malaria_NN
        treatment_NN guidelines_NNS ,_, especially_RB among_IN retail_JJ attendants_NNS
        with_IN less_JJR education_NN ._. The_DT programme_NN appears_VBZ to_TO have_VB had_VBN the_DT
        greatest_JJS impact_NN on_IN shops_NNS and_CC kiosks_NNS ._. These_DT effects_NNS could_MD be_VB
        heightened_VBN if_IN the_DT programme_NN addressed_VBD several_JJ issues_NNS more_RBR
        intensively_RB ,_, such_JJ as_IN building_NN consumer_NN demand_NN for_IN SP_NNP and_CC
        sustaining_VBG the_DT interest_NN of_IN wholesale_JJ attendants_NNS in_IN the_DT
        activity_NN ,_, perhaps_RB through_IN an_DT incentive_NN programme_NN ._. (_( The_DT
        district_NN launched_VBD a_DT "_'' neighbour-to-neighbour_JJ "_'' programme_NN in_IN
        2002_CD to_TO raise_VB public_JJ awareness_NN about_IN correct_JJ malaria_NN
        treatment_NN ._. )_)
        However_RB ,_, this_DT programme_NN will_MD not_RB be_VB able_JJ to_TO achieve_VB a_DT
        high_JJ degree_NN of_IN success_NN without_IN national_JJ policies_NNS and_CC
        programmes_NNS addressing_VBG the_DT profit_NN margins_NNS of_IN SP_NNP versus_CC AQ_NNP
        drugs_NNS ,_, advertising_NN and_CC sales_NNS of_IN unapproved_JJ drugs_NNS ,_, the_DT
        enforcement_NN of_IN correct_JJ dosage_NN labeling_VBG ,_, and_CC retrieval_NN from_IN
        the_DT market_NN of_IN inefficacious_JJ drugs_NNS ._. Moreover_RB ,_, the_DT national_JJ
        government_NN needs_VBZ to_TO be_VB more_RBR active_JJ in_IN educating_VBG consumers_NNS
        about_IN the_DT importance_NN of_IN early_JJ recognition_NN and_CC prompt_VB
        treatment_NN for_IN malaria_NN ,_, why_WRB SP_NNP is_VBZ the_DT preferred_JJ first-line_JJ
        drug_NN ,_, and_CC which_WDT drugs_NNS have_VBP been_VBN approved_VBN ._. Coupled_VBN with_IN
        these_DT national_JJ activities_NNS ,_, district-level_JJ vendor-to-vendor_JJ
        programmes_NNS would_MD probably_RB have_VB greater_JJR impact_NN ._.
      
      
        List_NN of_IN abbreviations_NNS used_VBN
        AMREF_NNP African_NNP Medical_NNP Research_NNP and_CC Education_NNP
        Foundation_NNP
        AQ_NNP amodiaquine_NN
        ANOVA_NNP analysis_NN of_IN variance_NN
        CQ_NNP chloroquine_NN
        DHMT_NNP District_NNP Health_NNP Management_NNP Team_NNP
        QAP_NNP Quality_NNP Assurance_NNP Project_NNP
        SP_NNP sulfadoxine-pyrimethamine_JJ
        USAID_NNP United_NNP States_NNPS Agency_NNP for_IN International_NNP
        Development_NNP
        WHO_WP World_NNP Health_NNP Organization_NNP
      
      
        Authors_NNP '_'' contributions_NNS
        PT_NNP conceived_VBD the_DT study_NN ,_, performed_VBN most_JJS of_IN the_DT data_NNS
        analysis_NN ,_, and_CC drafted_VBD the_DT results_NNS and_CC discussion_NN sections_NNS
        of_IN the_DT manuscript_NN ._. JS_NNP participated_VBD in_IN the_DT research_NN design_NN ,_,
        supervised_JJ data_NNS collection_NN ,_, and_CC drafted_VBD the_DT description_NN of_IN
        the_DT study_NN methodology_NN ._. SM_NNP participated_VBD in_IN the_DT research_NN
        design_NN and_CC performed_VBD some_DT of_IN the_DT data_NNS analysis_NN ._. All_DT authors_NNS
        read_VBP and_CC approved_VBD the_DT final_JJ manuscript_NN ._.
      
    
  
